stem cell transplantation in iran; 1991 until 2009

نویسندگان

ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran

kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran

mohammad jahani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran

seyed asad-o-allah mousavi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran

چکیده

hematology- oncology and stem cell transplantation research center related to tehran university of medical sciences located in shariati hospital. these center activities have started in 1991 in order to help needful patients and augment new data to reach new aspects of therapeutic trials. also it is one of the greatest stem cell transplantation centers in world and is the second center in the world based on the transplanted thalassemia patients. since 1991, 2426 first hematopoietic stem cell transplantation (hsct) has been performed in patients with different diseases. acute myelogenous leukemia (647 patients), thalassemia major (386 patients) and acute lymphoblastic leukemia (335 patients) were the most common transplanted disorders, respectively. there were 1662 cases that have received allogeneic hsct and 764 cases that have received autologous hsct. number of allogeneic ant autologous hsct is increased during the time, but the allogeneic to autologous ratio remains constant.the first peripheral blood hematopoietic stem cell transplantation was performed in 1996 and since then, there was 1988 patients were done with this method. the donor types for 1662 allogeneic first hsct were 1577 (94.9%) human leukocyte antigen (hla) matched-identical siblings, 44 (2.6%), hla mismatched sibling/other relative, 16 (1%) syngeneic twins, 18 (1.1%) hla matched other relative and 7 (0.4%) unrelated.   the first cord blood hematopoietic stem cell transplantation was performed in 1998 and since then there was 16 patients that have obtained cord blood transplantations. recently, new methods have been used like donor lymphocyte infusion (dli) and cellular therapy. there were 147 patients with cellular therapy for post mi, cirrhosis, thalassemia major, multiple sclerosis, head of femour necrosis and gvhd treatment.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

hematopoietic stem cell transplantation in iran: 1991 through 2010

introduction: this review reports the current results of hematopoietic stem cell transplantation (hsct) in patients who had received transplantation in the hematology-oncology and sct research center, tehran, iran. methods: in iran, from 1991 through 2010, a total of 3170 hematopoietic stem cell transplantation have been carried out. the male/female patient ratio was 1909/1261 with a median age...

متن کامل

Ethical Issues in Stem Cell Transplantation

There is great interest worldwide in discovering and developing a permanent source of tissues which would be capable of generating any cell type and which would avoid the problem of transplant rejection. Stem cells are cells that can specialize into the many different cells found in the human body. The ethical objections concerning stem cells have focused primarily on their source. Human embry...

متن کامل

Pediatric Hematopoietic Stem Cell Transplantation

The introduction and evolution of hematopoietic stem cell transplantation (HSCT) could be traced back to 1950s, to the studies on interactions among irradiation, covering spleen and bone marrow from it and injection of bone marrow cells. Today, HSCT is considered a well-established, effective and promising means of therapy for various malignant and non-malignant medical conditions, both in chil...

متن کامل

Osteoporosis after stem cell transplantation

Background Stem cell transplantation has become as a novel treatment  for end-stage kidney, lung, heart , liver diseases and several hematologic disorders. Improved survival of transplant recipients has raised awareness of post-transplant complications. One of these complications is transplant-related osteoporosis. Methods  In this manuscript we review prevention methods for transplant-relat...

متن کامل

Advances in Hematopoietic Stem Cell Mobilization and Peripheral Blood Stem Cell Transplantation

Hematopoietic stem/progenitor cells (HSPCs) which give rise to different blood cell types are present within the bone marrow microenvironment, especially in flat bones such as skull, vertebrae, pelvis and chest. Interacting factors such as stromal derived factor-1/CXCR4, very late antigen-4/vascular cell adhesion molecule-1, Lymphocyte function-associated antigen-1/ intercellular adhesion molec...

متن کامل

Twenty Years of Experience on Stem Cell Transplantation in Iran

BACKGROUND Hematopoietic stem cell transplantation (HSCT) is a new window to therapy of many diseases. From March 1991 through April 2011, a total of 3237 HSCT were performed in the Hematology-Oncology and Stem Cell Transplantation Research Center, affiliated to Tehran University of Medical Sciences. Here we report 20 years experience of HSCT. OBJECTIVES Our strategy and aim include the protr...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
international journal of hematology-oncology and stem cell research

جلد ۳، شماره ۱، صفحات ۲۷-۳۳

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023